Ha Tay Pharmaceutical JSC (HNX:DHT)

Ha Tay Pharmaceutical JSC Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Market Capitalization	6,331,125	7,822,325	1,893,826	1,027,245	950,663	1,126,008
Market Cap Growth	-10.59%	313.04%	84.36%	8.06%	-15.57%	9.67%
Enterprise Value	6,527,554	8,001,132	2,176,376	1,106,314	835,889	1,287,133
Last Close Price	69900.00	86363.64	20336.49	12284.00	13536.16	16032.83
PE Ratio	95.11	108.99	22.27	10.79	13.99	12.23
PS Ratio	2.81	3.75	0.95	0.56	0.59	0.56
PB Ratio	5.75	7.40	1.78	1.29	1.26	3.22
P/TBV Ratio	5.89	7.61	1.83	1.33	1.31	3.47
P/FCF Ratio	121.20	-	-	-	-	198.37
P/OCF Ratio	114.82	279.78	6.99	-	-	11.89
EV/Sales Ratio	2.90	3.84	1.09	0.60	0.52	0.64
EV/EBITDA Ratio	72.31	82.49	18.71	9.23	10.65	10.49
EV/EBIT Ratio	94.61	104.57	21.94	10.80	13.47	11.76
EV/FCF Ratio	124.96	-	-	-	-	226.75
Debt / Equity Ratio	0.34	0.45	0.47	0.42	0.38	0.58
Debt / EBITDA Ratio	4.69	4.85	4.33	2.81	3.69	1.66
Debt / FCF Ratio	7.26	-	-	-	-	35.97
Asset Turnover	-	1.11	1.21	1.36	1.49	2.42
Inventory Turnover	-	4.12	4.28	4.12	4.08	4.92
Quick Ratio	0.45	0.41	0.81	0.47	1.15	0.56
Current Ratio	1.23	1.21	1.69	1.80	2.10	1.30
Return on Equity (ROE)	-	7.08%	9.54%	12.75%	12.95%	29.05%
Return on Assets (ROA)	-	2.54%	3.75%	4.73%	3.60%	8.26%
Return on Invested Capital (ROIC)	3.70%	4.76%	7.34%	10.22%	9.03%	19.47%
Return on Capital Employed (ROCE)	5.00%	6.60%	8.00%	11.30%	8.20%	30.90%
Earnings Yield	1.05%	0.92%	4.49%	9.27%	7.15%	8.18%
FCF Yield	0.83%	-1.47%	-5.05%	-27.84%	-8.82%	0.50%
Dividend Yield	1.30%	-	-	-	2.40%	-
Payout Ratio	58.62%	111.73%	-	53.87%	29.96%	48.22%
Buyback Yield / Dilution	-	-62.83%	-	-	0.77%	-
Total Shareholder Return	1.31%	-62.83%	-	-	3.17%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.